“Efficacy and Safety of Tralokinumab in Adolescents With Moderate-to- Severe Atopic Dermatitis: Results of the Phase 3 ECZTRA 6 Trial”. SKIN The Journal of Cutaneous Medicine 6, no. 2 (March 4, 2022): s29. Accessed April 3, 2025. https://skin.dermsquared.com/skin/article/view/1546.